| Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training. | |
| | |
MedLine Citation:
|
PMID: 22264574 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: Non-high density lipoprotein cholesterol (non-HDL-C) goal attainment per Adult Treatment Panel III (ATP III) guidelines remains low. OBJECTIVE: To understand gaps in knowledge and practices of physicians-in-training (internal medicine, family medicine, cardiology, endocrinology) towards non-HDL-C. METHODS: A survey based on a conceptual model to assess the trainee's knowledge, attitudes, and practice regarding non-HDL-C was developed and administered to physicians-in-training (n = 655) at 26 training programs in the United States. Responses of those in internal medicine and family medicine (residents-in-training; n = 418) were compared with those in cardiology and endocrinology (fellows-in-training; n = 124). RESULTS: Response rate was 83.7%. Fifty-three percent of residents and 31% of fellows-in-training had not read the ATP III guidelines (P < .001). Thirty-three percent of the residents and 35% fellows-in-training could not calculate non-HDL-C from a standard lipid panel (P = .7). Sixty-seven percent of the residents and 52% of fellows were not aware of treatment goals for non-HDL-C (P = .004 for comparison between residents and fellows). Both residents and fellows reported infrequent calculation of non-HDL-C levels in patients with elevated triglycerides (≥200 mg/dL; 32.5% vs 35.4%, respectively, P = .6). Lack of familiarity with ATP III guidelines, lack of knowledge regarding importance of non-HDL-C, lack of institutional mandate to calculate non-HDL-C, and lack of emphasis on non-HDL-C by teaching staff were reported as barriers to non-HDL-C use in routine clinical practice. CONCLUSIONS: At least one-third of physicians-in-training could not calculate non-HDL-C from a standard lipid panel, and a large number were not aware of ATP III treatment goals pertaining to non-HDL-C. This area represents one for improvement if non-HDL-C is to be retained as a treatment target in the forthcoming ATP-IV guidelines. |
| | |
Authors:
|
Smita I Negi; Lynne Steinberg; Venkateshwar R Polsani; Saqib A Gowani; Vijay Nambi; Varinder Kumar; Victor Marinescu; Peter H Jones; Laura A Petersen; Christie M Ballantyne; Salim S Virani |
Related Documents
:
|
7779334 - Journal clubs. prevalence, format, and efficacy in pm&r. 12913374 - Are family practice residents able to interpret electrocardiograms? 17040954 - Online database for documenting clinical pathology resident education. 17122484 - Developing an institution-based assessment of resident communication and interpersonal ... 21945074 - Mirnas control tracheal chondrocyte differentiation. 22007114 - Hate crimes on campus: racial/ethnic diversity and campus safety. |
Publication Detail:
|
Type: Journal Article Date: 2011-11-07 |
Journal Detail:
|
Title: Journal of clinical lipidology Volume: 6 ISSN: 1933-2874 ISO Abbreviation: J Clin Lipidol Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-01-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101300157 Medline TA: J Clin Lipidol Country: United States |
Other Details:
|
Languages: eng Pagination: 50-7 Citation Subset: IM |
Copyright Information:
|
Published by Elsevier Inc. |
Affiliation:
|
Section of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The differential effect of statins on oxidative stress and endothelial function: Atorvastatin versus...
Next Document: Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiova...